एपीए उद्धरण

Drake, M. J., MacDiarmid, S., Chapple, C. R., Esen, A., Athanasiou, S., Cambronero Santos, J., . . . Stoelzel, M. (2017). Cardiovascular safety in refractory incontinent patients with overactive bladder receiving add‐on mirabegron therapy to solifenacin (BESIDE). Int J Clin Pract.

शिकागो स्टाइल उद्धरण

Drake, Marcus J., et al. "Cardiovascular Safety in Refractory Incontinent Patients With Overactive Bladder Receiving Add‐on Mirabegron Therapy to Solifenacin (BESIDE)." Int J Clin Pract 2017.

एमएलए उद्धरण

Drake, Marcus J., et al. "Cardiovascular Safety in Refractory Incontinent Patients With Overactive Bladder Receiving Add‐on Mirabegron Therapy to Solifenacin (BESIDE)." Int J Clin Pract 2017.